| European Case Law Identifier: | ECLI:EP:BA:2016:T099613.20160606 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 06 June 2016 | ||||||||
| Case number: | T 0996/13 | ||||||||
| Application number: | 06120391.5 | ||||||||
| IPC class: | C12N 15/12 C07K 14/705 C07K 16/28 C12Q 1/68 G01N 33/68 A61P 13/08 A61K 38/17 A61K 39/395 A01K 67/027 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | 13 Transmembrane protein expressed in prostate cancer | ||||||||
| Applicant name: | Agensys, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Claim request filed with statement of Grounds of Appeal (inadmissible) Appeal dismissed |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t130996eu1.html
Date retrieved: 17 May 2021